Avascular Necrosis of the Scaphoid Preiser Disease

Abstract

No consensus regarding optimal treatment or etiology of Preiser disease exists. We described the epidemiology,<br />classification and treatment characteristics of 18 patients with Preiser disease. Patients with changes related to previous<br />trauma, and without radiographs were excluded. Based on the radiographs at diagnosis, we classified 13 scaphoids as<br />Herbert Lanzetta stage II, four as stage III, and one as stage IV. In 12 patients nonspecific treatment was offered and<br />only two patients received surgical treatment. We found that chosen treatment is not associated with the severity of<br />Herbert Lanzetta stage and the outcome is not influenced by chosen treatment.<br />Level of evidence: I